ID: ALA28468

Max Phase: Preclinical

Molecular Formula: C10H14N2O4S

Molecular Weight: 258.30

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1ccc(N)c(S(=O)(=O)CC(N)C(=O)O)c1

Standard InChI:  InChI=1S/C10H14N2O4S/c1-6-2-3-7(11)9(4-6)17(15,16)5-8(12)10(13)14/h2-4,8H,5,11-12H2,1H3,(H,13,14)

Standard InChI Key:  VJJCBQQQYNTFQL-UHFFFAOYSA-N

Associated Targets(non-human)

Kynureninase 17 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 258.30Molecular Weight (Monoisotopic): 258.0674AlogP: -0.24#Rotatable Bonds: 4
Polar Surface Area: 123.48Molecular Species: ACIDHBA: 5HBD: 3
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 5#RO5 Violations (Lipinski): 0
CX Acidic pKa: 0.80CX Basic pKa: 7.73CX LogP: -2.72CX LogD: -2.87
Aromatic Rings: 1Heavy Atoms: 17QED Weighted: 0.64Np Likeness Score: -0.67

References

1. Drysdale MJ, Reinhard JF..  (1998)  S-aryl cysteine S,S-dioxides as inhibitors of mammalian kynureninase.,  (2): [PMID:9871640] [10.1016/s0960-894x(97)10209-8]

Source